scorecardresearch
Add as a preferred source on Google
Tuesday, April 7, 2026
TopicPatent

Topic: patent

As semaglutide goes off patent, weight-loss gold rush begins. Pharma bets big, court case lingers

Several leading Indian drugmakers have already secured regulatory approval or recommendations to produce and market generic versions of the weight loss drugs in India.

SC declines to restrain Zydus from selling cancer drug biosimilar, tells Bristol Myers to approach HC

A bench headed by the Chief Justice of India suggests Squibb to conduct a mapping exercise of Zydus product with their claimed patent to ascertain infringement, if any.

Roche patent case: Why SC refused to halt Natco’s generic spinal muscular atrophy drug Risdiplam

Roche had approached Delhi High Court, accusing Natco of violating its Indian patent, before going to the Supreme Court with its petition.

Govt grants patent to Bengaluru firm for first-of-its-kind system to manage Aadhaar data

SISA says its newly patented system will help streamline automated detection, masking, and secure management of Aadhaar data across various platforms without user intervention.

Delhi High Court restores PepsiCo’s patent for potato variety used to make Lay’s

In 2019, PepsiCo sued some Indian farmers for cultivating FC5 potato variety, accusing them of infringing its patent. It sought over Rs 10mn each for alleged patent infringement.

Pandemic can’t be allowed to devastate nations because of sophisticated, one-sided WTO rules

For President Joe Biden to take a stand against pharmaceutical companies is no small matter. His presidential campaign was the near sole beneficiary of pharma largesse in 2020.

Johnson & Johnson, Modi govt at odds over compensation for faulty hip implants

Government says Johnson & Johnson has put it 'in writing' that it will pay aid but firm remains vague in its response on the subject.

On Camera

India must reduce its dependence on fertiliser imports before it’s too late

What worsens India’s dependence on fertiliser imports is not merely the volume of imports, but the inefficiency with which the country utilises them.

Syringes, MRI to ventilators, West Asia war squeezing India’s medical supply chain—costs up 10 to 50%

Industry says manufacturers have 2-4 weeks of buffer stocks, but prolonged disruption could push up shortage risks, especially of consumables like IV and syringes.

UAE walks away from financing Rafale F5 due to restricted access to technology, reports French media

French newspaper La Tribune earlier last week indicated that UAE withdrew from deal to fund EUR 3.5 billion. India is looking to order 114 new Rafales, which could include the F5.

China insulated itself against energy shocks. India is ‘all talk, no walk’

China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.